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Objective. Intrauterine growth restriction (IUGR) is a major cause of late stillbirth, though not all compromised babies remain small
or are considered growth restricted as pregnancy progresses. Fetal Magnetic Resonance Imaging (f-MRI) represents a second-line
tool to study pregnancies with IUGR fetuses. The aim of our study was to evaluate the usefulness of f-MRI on predicting fetal
growth and the oﬀspring’s perinatal respiratory outcome. Design. All f-MRI performed between 2014 and 2016 in Siena were
analysed. Pregnancies with IUGR (Study group (SG)) were recruited together with a control population (Control group (CG)),
coupled for gestational age (GA) at the time of f-MRI (mean GA 31 wks). Neonatal information was collected. The f-MRI
protocol consisted of T2w images. Six regions of interest (ROI) were placed as follows: 2 on the lung, 2 on the liver, and 2 on
the amniotic ﬂuid. The signal intensities (SI) of each ROI were measured. The SI lung to liver ratio (SI lung/liver) and SI lung to
amniotic ﬂuid ratio (SI lung/amniotic ﬂuid) were obtained for each fetus. Each ratio was compared between SG and CG.
Therefore, SG was divided into two subgroups: adequate and small for gestational age (AGA and SGA) newborns. All
measurements were related to oﬀspring’s perinatal respiratory outcome. Results. SI lung/liver was linearly related with GA at the
time of f-MRI and with EFW. SI lung/amniotic ﬂuid was signiﬁcantly higher in SG than in CG (p = 0,014). In contrast, among
SG, lower values of SI lung/amniotic ﬂuid were found in the SGA compared to AGA (p = 0,036). The days of oxygen supply
were higher in the SGA subgroup than in the AGA subgroup (p = 0,028). Conclusions. SI lung/liver increases with fetal lung
maturation and appears to be useful to estimate intrauterine fetal growth. SI lung/amniotic ﬂuid seems to be a reliable predictive
index to distinguish the IUGR fetuses that can recover their growth from those that were born SGA. f-MRI represents a
promising frontier to predict IUGR fetus outcome, thus contributing to ameliorate the perinatal management.
1. Introduction
Complex and dynamic interactions between maternal, pla-
cental, and fetal environments are involved in ensuring nor-
mal fetal growth. The impairment of this system may lead to
intrauterine growth restriction (IUGR) [1]. If in utero alter-
ations persist, fetuses can be born small for gestational age
(SGA). Thus, the terms IUGR and SGA, although related,
are not synonymous: IUGR deﬁnes deviation from the
expected (potential) fetal growth pattern; SGA describes an
infant whose weight at birth is lower than a predetermined
cut-oﬀ weight. The cause may be pathologic, in the case of
an infant with IUGR, or non-pathologic, in the case of an
infant who is small but healthy [2].
Being born SGA is associated with many short-term
complications like increased mortality, lung disease, hypo-
tension, necrotizing enterocolitis, poor thermoregulation,
hypoglycaemia, and polycythaemia. In addition, long-term
complications, like insulin resistance, type II diabetes melli-
tus, cardiovascular disease, neurodevelopmental and stature
delay, and cognitive and behavioural problems, may occur in
SGA newborns later in life [3].
There is no consensus on which fetal monitoring
modalities should trigger delivery in fetal growth restric-
tion between 32 and 36+6 weeks, and practice varies widely
worldwide [4, 5]. The consequences of inappropriately
early or late delivery for perinatal and infant health and
maternal morbidity are potentially enormous. Current
interest lies in the use of fetal ultrasound (f-US) as the
gold standard for screening fetal growth, because it provides
real-time images with excellent resolution, repeatable with
good cost-eﬀectiveness [6, 7]. However, few useful US
parameters are available to predict neonatal outcome and
aid in making therapeutic decisions. To discover a fetus at
risk of severe IUGR is of paramount importance in the
timing of delivery to optimise perinatal outcome.
In the past, Fetal Magnetic Resonance Imaging (f-MRI)
was used in pregnancies but fetal anatomy was not
adequately visualised with conventional sequences due to
long acquisition times [8]. This problem was overcome with
the introduction of fast and ultrafast sequences that reduced
fetal motion artefacts, in particular T2-weighted sequences.
[9] Nowadays, f-MRI is used as a second-line method to
study obstetric disorders, fetal anomalies, gravid uterus, and
placenta diseases [10, 11]. Moreover, f-MRI is capable of
informing on the development of individual organs and their
additional maturational changes [12]. For example, f-MRI
assessment of the fetal lung leads to speciﬁc evaluation of
the following: (i) the fetal lung volumetry, used to identify
restricted and insuﬃcient lung growth; (ii) the signal intensi-
ties (SI), used to analyse the maturational status of the fetal
lung; and (iii) the high resolution and tissue contrast, used
to oﬀer more detailed information of fetal pulmonary
pathologies. These techniques are used in conditions such as
oligohydramnios, congenital diaphragmatic hernia, and
pulmonary hypoplasia, where studying fetal lung growth
and its maturation plays a key role in postnatal survival [13].
In the case of IUGR, placental function and fetal health are
usually assessed by ultrasound biometry, Doppler velocimetry
measurements, and cardiotocography [4]. f-MRI is used infre-
quently for the diagnosis of IUGR outside research settings.
The aim of this work was to evaluate the usefulness
of f-MRI in the outcome of IUGR fetus and to study
the role of lung intensity signal in predicting perinatal
respiratory outcome.
2. Materials and Methods
2.1. Study Design. All f-MRI performed at “S. Maria alle
Scotte” Hospital, in Siena, between May 2014 and October
2016, were analysed. All IUGR pregnancies with gestational
age (GA) at the time f-MRI between 29 and 32 weeks were
selected (Study group (SG)). Congenital malformations,
chromosomal abnormalities, inborn errors of metabolism,
outborn birth, and multiple pregnancies were considered
the exclusion criteria. The Control group (CG) included
fetuses without IUGR, matched for gestational age at the time
of f-MRI. The study protocol was approved by the local ethics
board. Written informed consent was obtained from the
mother before the enrollment.
2.2. Population. The estimated fetal weight (EFW) was
calculated with Hadlock’s method using measurements of
biparietal diameter (BPD), head circumference (HC),
abdominal circumference (AC), and femur length (FL) of
the f-US performed nearest to the f-MRI. IUGR was deﬁned
as fetus with AC or EFW below the 10th percentile. A total of
8 pregnancies with IUGR were enrolled in the study, together
with a control population of 10. All pregnancies were followed
until parturition. At birth, newborns weighing below the 10th
centile expected for their GA were considered SGA [14].
In order to discriminate the fetuses that recover their
growth from those who were born with a birth weight
lower than a predetermined cut-oﬀ, the IUGR population
was also divided in the adequate for gestational age
(AGA) and SGA subgroups.
For each newborn, the following perinatal data were
collected: GA and weight at birth; percentiles of weight,
length, and head circumference; 1 and 5-minute APGAR
score; length of oxygen therapy in days; and maximum
FiO₂ levels delivered in the ﬁrst week of life.
2.3. MRI Scans. All f-MRI were performed using a 1.5 T
scanner (Signa Excite TwinSpeed HDx, GE Healthcare,
Milwaukee, USA) with an eight-channel phased-array
surface coil. To prevent supine hypotension syndrome,
the examinations were conducted with mothers in a left
lateral tilt position.
The imaging protocol consisted of a T2-weighted
single-shot turbo spin echo sequences (TR 1000msec; TE
80msec; matrix: 224x224; acceleration factor ASSET 2; slice
thickness: 3mm).
The image analysis was performed on a workstation
(Advantage Windows 4.4, GE Healthcare, USA), and 6 ROIs
(Region of Interest) of 200mm2 were placed as follows: 2
ROIs on the lung, 2 on the liver, and 2 on the amniotic ﬂuid
(Figure 1). The signal intensities (SI) of lung, liver, and amni-
otic ﬂuid were quantiﬁed, and the average, for each structure,
was calculated. As SI of any tissue would depend on the dis-
tance from the coil, absolute values are not appropriate to use
and therefore a ratio comparing the SI of the lungs with a
reference structure at a comparable depth was introduced
[15]. The liver and the amniotic ﬂuid were the reference
structures used so far, due to the assumption that they are
adjacent to the lungs and, more importantly, that they would
not change with increasing GA [16, 17]. Therefore, the SI
lung to liver ratio (SI lung/liver) and SI lung to amniotic ﬂuid
ratio (SI lung/amniotic ﬂuid) were obtained for each fetus.
2.4. Statistical Analysis. A descriptive analysis of the popula-
tion was conducted. For the inferential analysis, SI lung/liver
and SI lung/amniotic ﬂuid were correlated to fetus anthropo-
metric measures using Spearman’s test. Diﬀerences between
groups (IUGR vs. Control and AGA vs. SGA) were studied
using the Mann-Whitney test.
All the results were also correlated to the subsequent
perinatal respiratory outcome in terms of length of oxygen
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supply in days and the maximum inspired oxygen fraction
administered in the ﬁrst week of life using the Mann-
Whitney test. The data were analysed using SPSS v.20.0
software for Windows.
All statistical tests were two-tailed with signiﬁcance
level p < 0, 05.
3. Results
The population characteristics are shown in Table 1.
Regarding the GA at the time of f-MRI or GA at birth, no
statistical diﬀerences were found between SG and CG. The
general mean GA at the time of f-MRI was 31, 6 ± 0, 88weeks
of gestation.
SG had lower EFW and birth weight (BW) than the
CG (p < 0, 05).
SI lung/liver was linearly related to GA at the time of
f-MRI (Rho = 0,858; p < 0,001) (Figure 2(a)) and with
EFW (Rho = 0,794; p < 0,001) (Figure 2(b)).
SI lung/amniotic ﬂuid showed no correlation with
anthropometric measures but was signiﬁcantly higher in
the SG than in the CG (respectively, 0, 80 ± 0, 06 and 0,
71 ± 0, 06; p = 0,014) (Figure 3(a)). SI lung/liver was not
signiﬁcantly diﬀerent between the groups.
There was a longer duration of oxygen use within the
IUGR population (IUGR: 12, 25 ± 8, 13 vs. Control: 1, 9 ± 1,
01; p = 0,005) (Figure 3(b)).
In contrast, among IUGR fetuses, lower values of SI
lung/amniotic ﬂuid were found in the SGA population in
comparison with AGA (respectively, 0, 63 ± 0, 07 and 0, 9
± 0, 06; p = 0,036) (Figure 4(a)). SGA newborns received
oxygen therapy longer than AGA (30, 66 ± 18, 52 vs. 1, 2
± 0, 96 days; p = 0,028) (Figure 4(b)).
4. Discussion
The fetus with IUGR represents a public health problem, and
it is the second most common cause of perinatal mortality
and morbidity, after the preterm delivery. It is important to
enhance the fetal management techniques in order to amelio-
rate IUGR prenatal and postnatal outcome.
This is the ﬁrst study that investigates the usefulness of
the f-MRI in the evaluation of IUGR perinatal outcome,
demonstrating that f-MRI parameters may be used to esti-
mate fetal growth trends. Signiﬁcant associations between
the SI lung/liver and gestational age and EFW at the time of
f-MRI were found in our study [16].
Given that the reference structure does not change during
pregnancy, the increase of the SI value in the ratio lung/liver
means that the lung increases its water content during gesta-
tion. In fact, fetal lung ﬂuid secretion increases during gesta-
tion and correlates with progressive pulmonary development
and maturation: when the volume of fetal lung ﬂuid is abnor-
mally small, lung hypoplasia occurs, and in contrast, excess
fetal lung ﬂuid results in lung hyperplasia [17, 18]. The SI
amniotic ﬂuid/lung allowed to distinguish the IUGR fetuses
that would recover their growth from those that would have
been born SGA. The reduction in the SI ratio in SGA infants
could be due to a premature resorption of pulmonary ﬂuids
due to fetal stress or an adverse intrauterine environment
that did not determine the correct achievement of growth
potential. It would be also plausible that IUGR fetuses that
do not regain growth and are born SGA have a primitive lung
development disorder.
Although secretion of ﬂuid into the lung lumen is vital for
growth of the fetal lung, this ﬂuid must be removed at birth to
help the newborn convert from “liquid breathing” to “air
breathing” mode. Fetal lung secretion declines in the last
few days before the labour [19], and the lung epithelium
absorption begins. This process is mediated through the
activation of airway epithelial sodium channels (ENaC). In
humans, postnatal ENaC expression is gestational age-
dependent, and its activity correlates with lung compliance.
It is therefore likely that in the human newborn infant ENaC
is also important for physiologic postnatal adaptation. Low
pulmonary expression or activity of ENaC in the perinatal
period may cause delayed clearance of lung ﬂuid and thereby
contribute to the development of respiratory distress in both
term and preterm infants. [20] In our study, SI lung/amniotic
ﬂuid was signiﬁcantly higher in the IUGR group than in the
Control group. This increase in water content can explain
the diﬀerent respiratory outcomes of the two groups; in fact,
the length of oxygen therapy was signiﬁcantly higher in the
IUGR group.
Unexpectedly, SI lung/amniotic ﬂuid was found to be
signiﬁcantly lower in the SGA than in AGA subgroups and
the days of oxygen therapy were higher in the SGA newborn
than in the AGA subgroup. According to our knowledge, this
result has never been reported in the literature.
Epinephrine, O₂, glucocorticoid, and thyroid hormones
interact to stimulate Na+ absorption by increasing Na+
pump activity [24]. IUGR fetuses are overexposed to the
eﬀects of glucocorticoids [26]: their increase during fetal
development may contribute to facilitate the absorption
of the pulmonary ﬂuid.
IUGR fetuses that do not recover their growth are exposed
to greater in utero stress condition, and the acceleration of
pulmonary development may result to a worse respiratory
Figure 1: Coronal SSFSE T2-weighted image where 6 ROI (regions
of interest were placed: 2 on the lung, 2 on the liver, and 2 on the
amniotic ﬂuid).
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outcome due to a premature activation of the absorption
phase that impairs the normal lung development.
5. Conclusions and Future Perspectives
The data analysis allowed the identiﬁcation of a set of f-
MRI parameters useful to predict perinatal outcome of
IUGR fetuses.
SI lung/liver was related to anthropometric measure-
ments and could become a potential index of fetal lung
maturation, thus useful to estimate intrauterine fetal
growth. In contrast, SI lung/amniotic ﬂuid could be an
index capable to predict the respiratory outcome and to
distinguish the IUGR fetuses that can recover their growth,
from those that are born SGA.
f-MRI represents a promising frontier to predict IUGR
fetal outcome, thus contributing indications about how to
treat fetal growth restriction in utero. Accordingly, fMRI
might still be systematically performed when IUGR is
diagnosed, in order to provide information relevant for
growth and respiratory outcome of the fetuses, needing a
closer follow-up.
fMRI could be a reliable aid for managing neonatal
intensive care treatment and parent counselling since a
normal/subnormal MRI would oﬀer a reassuring prognosis.
Further studies with a larger number of fetuses and
neonates are needed, particularly involving the addition of
Table 1: Clinical characteristic of population study.
Total n = 18 SG n = 8 CG n = 10
Maternal age 33, 35 ± 4, 1 35, 5 ± 3, 5 32, 2 ± 4, 2
GA at f-MRI (weeks) 31, 47 ± 3, 79 30, 57 ± 4, 19 32, 1 ± 3, 57
EFW (g) 1827, 17 ± 720,45 1533, 14 ± 780,16 2033 ± 634,56
GA at birth (weeks) 37, 23 ± 2, 81 36, 42 ± 3, 64 37, 8 ± 2, 09
Weight at birth (g) 2800, 0 ± 635,64 2430, 71 ± 800,48 3058, 5 ± 332,87∗
Weight percentile 39, 47 ± 26, 41 19, 07 ± 12, 13 53, 75 ± 24, 33
Length at birth (cm) 47, 11 ± 3, 75 45, 0 ± 4, 47 48, 60 ± 2, 41
Length percentile 36, 88 ± 25, 52 18, 50 ± 12, 2 49, 75 ± 24, 73
Head circumferences (cm) 33, 04 ± 2, 56 31, 58 ± 3, 45 34, 07 ± 0, 96∗
Head percentile 44, 26 ± 27, 06 28, 29 ± 22, 44 55, 45 ± 25, 06
APGAR 1 8, 7 ± 1, 26 8, 71 ± 1, 25 8, 7 ± 1, 33
APGAR 5 9, 23 ± 1, 2 9, 28 ± 1, 49 9, 2 ± 1, 03
Max FiO2 during the ﬁrst week of life 0, 24 ± 0, 06 0, 25 ± 0, 07 0, 24 ± 0, 05
Days of oxygen therapy 6, 58 ± 16, 34 13, 28 ± 24, 64 1, 9 ± 3, 2
∗p < 0:05.
Signal intensities lung/liver
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Figure 2: Correlation between SI of the lung/liver with GA (a) and EFW (b) at the time of f-MRI.
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clinical, biological, electrophysiological intensive care data.
Research eﬀorts in this ﬁeld will provide some deﬁnitive
answers to establish the optimal timing of delivery of IUGR,
in order to achieve their best outcome.
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Figure 3: SI lung/amniotic ﬂuid in the IUGR and Control groups (a); days of oxygen therapy in IUGR group (b).
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